The healthcare landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this method offers a simpler way to provide GLP-1 drugs. https://ronalddeav670110.blogripley.com/41749878/glp-1-patches-a-novel-approach-to-glucose-treatment